pith. sign in

arxiv: 1907.03512 · v1 · pith:G4SFK2IKnew · submitted 2019-07-08 · 🧬 q-bio.MN

Role of Toll-Like Receptors in the interplay between pathogen and damage associated molecular patterns

S. Chatterjee , B. S. Sanjeev This is my paper

Pith reviewed 2026-05-25 00:50 UTC · model grok-4.3

classification 🧬 q-bio.MN
keywords Toll-like receptorsPAMPsDAMPssuperoxide dismutasepathogen-host interactionsoxidative stressinflammatory diseases
0
0 comments X

The pith

Toll-like receptors link pathogen signals from bacteria and viruses to host damage responses via common protein targets.

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The paper analyzes interactions between 17 bacterial and viral pathogens and human hosts by modeling preferential attachment to receptor homologs. It establishes that Toll-like receptors serve as the key connection point between pathogen-associated molecular patterns and damage-associated molecular patterns. The work also identifies SOD1 and SOD2 as essential for countering oxidative stress in these pathways. A sympathetic reader would see this as a route to new anti-inflammatory treatments because it highlights shared mechanisms that could be targeted clinically.

Core claim

Through analysis of protein interactions in 17 pathogenic species, the study identifies Toll-like receptors as central to linking pathogen-associated molecular patterns (PAMPs) from bacteria and viruses with damage-associated molecular patterns (DAMPs) in the host, and highlights superoxide dismutases SOD1 and SOD2 as essential antioxidants mitigating oxidative stress from these interactions. Such strategies can be used as new therapies for anti-inflammatory diseases with significant clinical outcomes.

What carries the argument

Toll-like receptors (TLRs) identified via preferential attachment modeling as mediators between PAMPs (such as bacterial lipopolysaccharides and viral nucleic acids) and DAMPs.

If this is right

  • TLRs act as the shared node that allows pathogens to trigger both direct recognition and indirect host-damage signals.
  • SOD1 and SOD2 reduce reactive oxygen species damage generated during the PAMP-DAMP interplay.
  • Common human proteins targeted by multiple pathogens point to conserved entry points for intervention.
  • Therapeutic strategies aimed at TLRs or SOD enzymes could address inflammation across bacterial and viral infections.

Where Pith is reading between the lines

These are editorial extensions of the paper, not claims the author makes directly.

  • If the homolog-based predictions hold in wet-lab tests, they could prioritize which TLRs to modulate first in specific diseases.
  • Broad anti-inflammatory effects might arise from SOD-focused interventions even when the initial trigger is unknown.
  • The computational approach could be extended to additional pathogen classes to test whether TLR centrality persists.

Load-bearing premise

Preferential attachment of bacteria or viruses to their human receptor homologs correctly identifies the actual interacting proteins that drive the TLR response.

What would settle it

Cell-based assays that measure direct binding or signaling and find no TLR involvement in responding to both a PAMP and a DAMP from the same pathogen would falsify the claimed central role.

Figures

Figures reproduced from arXiv: 1907.03512 by B. S. Sanjeev, S. Chatterjee.

Figure 1
Figure 1. Figure 1: The Pathogen-Host Network depicting the interactions (edges) between human and pathogenic [PITH_FULL_IMAGE:figures/full_fig_p003_1.png] view at source ↗
Figure 2
Figure 2. Figure 2: Node Degree Distribution depicts the scale-free network topology of our pathogen-host network. [PITH_FULL_IMAGE:figures/full_fig_p004_2.png] view at source ↗
Figure 3
Figure 3. Figure 3: Topological Coefficient is used to estimate the tendency of the nodes to have shared neighbors in [PITH_FULL_IMAGE:figures/full_fig_p005_3.png] view at source ↗
Figure 4
Figure 4. Figure 4: Betweenness Centrality 5 [PITH_FULL_IMAGE:figures/full_fig_p005_4.png] view at source ↗
Figure 5
Figure 5. Figure 5: The blue-colored regions depict Leucine Rich Repeat regions (LRRs) of Toll-like receptors. Based [PITH_FULL_IMAGE:figures/full_fig_p006_5.png] view at source ↗
Figure 6
Figure 6. Figure 6: Toll-like receptor (TLR) Signaling Pathway are membrane-bound host (human) proteins that [PITH_FULL_IMAGE:figures/full_fig_p006_6.png] view at source ↗
read the original abstract

Various theoretical studies have been carried out to infer relevant protein-protein interactions among pathogens and their hosts. Such studies are generally based on preferential attachment of bacteria / virus to their human receptor homologs. We have analyzed 17 pathogenic species mainly belonging to bacterial and viral pathogenic classes, with the aim to identify the interacting human proteins which are targeted by both bacteria and virus specifically. Our study reveals that the TLRs play a crucial role between the pathogen-associated molecular patterns (PAMPs) and the damage associated molecular patterns (DAMPS). PAMPs include bacterial lipopolysaccharides (LPs), endotoxins, bacterial flagellin, lipoteichoic acid, peptidoglycan in bacterial organisms and nucleic acid variants associated with viral organisms, whereas DAMPs are associated with host biomolecules that perpetuate non-infectious inflammatory responses. We found out the presence of SOD1 and SOD2 (superoxide dismutase) is crucial, as it acts as an anti-oxidant and helps in eliminating oxidative stress by preventing damage from reactive oxygen species. Hence, such strategies can be used as new therapies for anti-inflammatory diseases with significant clinical outcomes.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, simulated authors' rebuttal, and a circularity audit. Tearing a paper down is the easy half of reading it; the pith above is the substance, this is the friction.

Referee Report

2 major / 0 minor

Summary. The manuscript analyzes 17 pathogenic bacterial and viral species using a preferential-attachment model based on homology to human receptor proteins. It concludes that Toll-like receptors (TLRs) serve as a key bridge between pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs), identifies SOD1 and SOD2 as critical antioxidants mitigating oxidative stress, and proposes these findings as the basis for new anti-inflammatory therapies.

Significance. If the computational predictions were experimentally validated and the homology model shown to recover true interactions, the work could highlight shared host targets in infection-driven inflammation. As presented, however, the absence of any interaction lists, statistical thresholds, methods details, or external validation means the claims provide no new substantiated insight into TLR or SOD biology.

major comments (2)
  1. [Abstract] Abstract: the central claim that TLRs play a crucial role between PAMPs and DAMPs rests on an unvalidated preferential-attachment homology screen, yet the text supplies neither the interaction-prediction algorithm, any statistical thresholds, nor overlap with curated experimental PPI resources.
  2. [Abstract] Abstract: the identification of SOD1 and SOD2 as crucial antioxidants whose presence 'helps in eliminating oxidative stress' is derived solely from the same homology model; no evidence is given that these homologs correspond to functional interactions or that the model recovers known pathogen-host PPIs.

Simulated Author's Rebuttal

2 responses · 0 unresolved

We thank the referee for the constructive comments. We address each major point below, clarifying the computational approach and indicating revisions to improve transparency and detail.

read point-by-point responses

  1. Referee: [Abstract] Abstract: the central claim that TLRs play a crucial role between PAMPs and DAMPs rests on an unvalidated preferential-attachment homology screen, yet the text supplies neither the interaction-prediction algorithm, any statistical thresholds, nor overlap with curated experimental PPI resources.

    Authors: The full manuscript details the preferential-attachment model, which infers interactions via sequence homology between pathogen proteins and human receptor homologs across the 17 species. We acknowledge that the Methods section lacks explicit pseudocode for the attachment rule, numerical thresholds (e.g., E-value or percent identity cutoffs), and direct overlap statistics with databases such as STRING or IntAct. These elements will be added in revision, including the homology criteria employed and any post-hoc comparison to known host-pathogen interactions. revision: yes

  2. Referee: [Abstract] Abstract: the identification of SOD1 and SOD2 as crucial antioxidants whose presence 'helps in eliminating oxidative stress' is derived solely from the same homology model; no evidence is given that these homologs correspond to functional interactions or that the model recovers known pathogen-host PPIs.

    Authors: SOD1 and SOD2 were recovered as high-degree nodes in the homology-derived network, consistent with their known roles in mitigating oxidative stress during infection. The underlying model follows established preferential-attachment methods previously applied to host-pathogen inference. We agree that the original text does not demonstrate recovery of benchmark PPIs or functional validation. The revision will include a limitations paragraph, explicit model assumptions, and a call for experimental follow-up rather than claiming direct functional proof. revision: partial

Circularity Check

0 steps flagged

No circularity; observational screen applies external model without self-referential reduction

full rationale

The paper describes a computational screen of 17 pathogens to identify shared human targets, using the standard preferential-attachment-to-homologs approach stated in the abstract. No equations, parameter fits, self-citations, or uniqueness theorems appear in the provided text. The reported centrality of TLRs and SOD1/SOD2 is an output of applying that model to the chosen species list, not a quantity defined in terms of itself or recovered by construction from the inputs. The derivation chain therefore remains independent of the target claims.

Axiom & Free-Parameter Ledger

0 free parameters · 1 axioms · 0 invented entities

The central claim rests on the validity of preferential attachment for inferring interactions and on the 17 species being representative; no free parameters, additional axioms, or invented entities are identifiable from the abstract.

axioms (1)
  • domain assumption Preferential attachment of bacteria/virus to their human receptor homologs can be used to infer relevant protein-protein interactions among pathogens and hosts
    Explicitly stated in the abstract as the general basis for such theoretical studies.

pith-pipeline@v0.9.0 · 5731 in / 1261 out tokens · 41226 ms · 2026-05-25T00:50:53.727495+00:00 · methodology

discussion (0)

Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.

Lean theorems connected to this paper

Citations machine-checked in the Pith Canon. Every link opens the source theorem in the public Lean library.

What do these tags mean?
matches
The paper's claim is directly supported by a theorem in the formal canon.
supports
The theorem supports part of the paper's argument, but the paper may add assumptions or extra steps.
extends
The paper goes beyond the formal theorem; the theorem is a base layer rather than the whole result.
uses
The paper appears to rely on the theorem as machinery.
contradicts
The paper's claim conflicts with a theorem or certificate in the canon.
unclear
Pith found a possible connection, but the passage is too broad, indirect, or ambiguous to say the theorem truly supports the claim.

Reference graph

Works this paper leans on

30 extracted references · 30 canonical work pages

  1. [1]

    Lehnert, S

    T. Lehnert, S. Timme, J. Pollm¨ acher, K. H¨ unniger, O. Kurzai, M. T. Figge.Bottom-up modeling approach for the quantitative estimation of parameters in pathogen-host interactions . Front Microbiol, 2015, 6, 608

    work page 2015

  2. [2]

    Janet Piero, lex Bravo, Nria Queralt-Rosinach, Alba Gutirrez-Sacristn, Jordi Deu-Pons, Emilio Centeno, Javier Garca-Garca, Ferran Sanz, and Laura I. Furlong. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucl. Acids Res. , 2016

    work page 2016

  3. [3]

    N. T. Doncheva, Y. Assenov, F. S. Domingues, M. Albrecht. Topological analysis and interactive visual- ization of biological networks and protein structures. Nature Protocols, 2012, 7:670-685

    work page 2012

  4. [4]

    Assenov, F

    Y. Assenov, F. Ram´ ırez, S. E. Schelhorn, T. Lengauer, M. Albrecht. Computing topological parameters of biological networks. Bioinformatics, 2008, 24(2):282-284. 8

    work page 2008

  5. [5]

    U. Brandes. A Faster Algorithm for Betweenness Centrality. Journal of Mathematical Sociology , 2001, 25(2):163-177

    work page 2001

  6. [6]

    Girvan, M

    M. Girvan, M. E. Newman. Community structure in social and biological networks. Proc. Natl. Acad. Sci. USA , 2002, 99(12): 7821-7826

    work page 2002

  7. [7]

    D. J. Watts and Steven Strogatz. Collective dynamics of ‘small-world’ networks.Nature, 1998, 393 (6684): 440442

    work page 1998

  8. [8]

    Bernard, C

    J.J. Bernard, C. Cowing-Zitron, T. Nakatsuji, B. Muehleisen, J. Muto, A. W. Borkowski , L. Martinez, E .L. Greidinger, B. D. Yu, R. L. Gallo. Ultraviolet radiation damages self noncoding RNA and is detected by TLR3. Nature Medicine, 2012, 18 (8): 128690

    work page 2012

  9. [9]

    Becuwe, M

    P. Becuwe, M. Ennen, R. Klotz, C. Barbieux, S. Grandemange. Manganese superoxide dismutase in breast cancer - from molecular mechanisms of gene regulation to biological and clinical significance. Free Radical Biology & Medicine , 2014, 77: 139-151

    work page 2014

  10. [10]

    M. K. O’Banion. Cyclooxygenase-2: molecular biology, pharmacology, and neurobiology. Crit Rev Neu- robiol., 1999, 13 (1): 4582

    work page 1999

  11. [11]

    R. G. Kurumbail, J. R. Kiefer, L. J. Marnett. Cyclooxygenase enzymes: catalysis and inhibition. Curr. Opin. Struct. Biol. , 2001, 11 (6): 75260

    work page 2001

  12. [12]

    TNF Trafficking to Human Mast Cell Granules: Mature Chain-Dependent Endocytosis

    Olszewski, et al. TNF Trafficking to Human Mast Cell Granules: Mature Chain-Dependent Endocytosis. The Journal of Immunology , 2007, 178 (9): 57015709

    work page 2007

  13. [13]

    E. A. Carswell, L. J. Old, R. L. Kassel, S. Green, N. Fiore, B. Williamson. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA , 1975, 72 (9): 366670

    work page 1975

  14. [14]

    L. J. Walsh, G. Trinchieri, H. A. Waldorf, D. Whitaker, G. F. Murphy. Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1. Proc. Natl. Acad. Sci. USA , 1991, 88 (10): 42204

    work page 1991

  15. [15]

    Surget, M

    S. Surget, M. P. Khoury, J. C. Bourdon. Uncovering the role of p53 splice variants in human malignancy: a clinical perspective. OncoTargets and Therapy, 2013, 7: 57–68

    work page 2013

  16. [16]

    T. Miki, T. Matsumoto, Z. Zhao, C. C. Lee. p53 regulates Period2 expression and the circadian clock. Nat. Commun. , 2013, 4:2444-2444

    work page 2013

  17. [17]

    Schneider, M

    E. Schneider, M. Montenarh, P. Wagner. Regulation of CAK kinase activity by p53. Oncogene, 1998, 17: 2733-2741

    work page 1998

  18. [18]

    Degryse, Bernard

    B. Degryse, Bernard. The urokinase receptor system as strategic therapeutic target: challenges for the 21st century. Current Pharmaceutical Design , 2011, 17 (19): 18721873

    work page 2011

  19. [19]

    Matthews, M

    H. Matthews, M. Ranson, M. J. Kelso. Anti-tumour / metastasis effects of the potassium-sparing diuretic amiloride: an orally active anti-cancer drug waiting for its call-of-duty?. Int. J. Cancer , 2011, 129 (9): 205161

    work page 2011

  20. [20]

    D. A. Geller, C. J. Lowenstein, R. A. Shapiro, A. K. Nussler, M. Di Silvio, S. C. Wang, D. K. Nakayama, R. L. Simmons, S. H. Snyder, T. R. Billiar. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA , 1993, 90 (8): 34915

    work page 1993

  21. [21]

    O. A. Marcos-Contreras, S. Martinez de Lizarrondo, I. Bardou, C. Orset, M. Pruvost, A. Anfray, Y. Frigout, Y. Hommet, L. Lebouvier, J. Montaner, D. Vivien, M. Gauberti. Hyperfibrinolysis increases blood-brain barrier permeability by a plasmin-and bradykinin-dependent mechanism. Blood, 2016, 128 (20): 24232434

    work page 2016

  22. [22]

    A. C. Ferguson-Smith, Y. F. Chen, M. S. Newman, L. T. May, P. B. Sehgal, F. H. Ruddle. Regional localization of the interferon-beta 2/B-cell stimulatory factor 2/hepatocyte stimulating factor gene to human chromosome 7p15-p21. Genomics, 1988, 2 (3): 2038. 9

    work page 1988

  23. [23]

    Fillardi

    P. Fillardi. ACEi and ARBS in Hypertension and Heart Failure. Current Cardiovascular Therapy, Springer, Volume 5. pp. 1013

    work page

  24. [24]

    Bensi, G

    G. Bensi, G. Raugei, E. Palla, V. Carinci, D. Tornese Buonamassa, M. Melli. Human interleukin-1 beta gene. Gene, 1987, 52 (1): 95101

    work page 1987

  25. [25]

    J. R. Schoenborn, C. B. Wilson. Regulation of interferon-gamma during innate and adaptive immune responses. Adv. Immunol. Advances in Immunology , 2007, 96. pp. 41101

    work page 2007

  26. [26]

    K. Sea, S. H. Sohn, A. Durazo, Y. Sheng, B. F. Shaw, X. Cao, A. B. Taylor, L. J. Whitson, S. P. Holloway, P. J. Hart, D. E. Cabelli, E. B. Gralla, J. S. Valentine. Insights into the role of the unusual disulfide bond in copper-zinc superoxide dismutase. The Journal of Biological Chemistry , 2015, 290 (4): 240518

    work page 2015

  27. [27]

    Tkach, C

    M. Tkach, C. Rosemblit, M. A. Rivas, C. J. Proietti, M. C. Daz Flaqu, M. F. Mercogliano, W. Beguelin, E. Maronna, P. Guzmn, F. G. Gercovich, E. G. Deza, P. V. Elizalde, R. Schillaci. p42/p44 MAPK-mediated Stat3Ser727 phosphorylation is required for progestin-induced full activation of Stat3 and breast cancer growth. Endocrine-Related Cancer, 2013, 20 (2): 197212

    work page 2013

  28. [28]

    Bathgate, P

    D. Bathgate, P. Yu-Wai-Man, B. Webb, R. W. Taylor, B. Fowler, P. F. Chinnery. Recessive spastic paraparesis associated with complex I deficiency due to MTHFR mutations. Journal of Neurology, Neu- rosurgery, and Psychiatry , 2012, 83 (1): 115

    work page 2012

  29. [29]

    L. L. Xu, M. K. Warren, W. L. Rose, W. Gong, J. M. Wang. Human recombinant monocyte chemotactic protein and other C-C chemokines bind and induce directional migration of dendritic cells in vitro.Journal of Leukocyte Biology , 1996, 60 (3): 36571

    work page 1996

  30. [30]

    M. W. Carr, S. J Roth, E. Luther, S. S. Rose, T. A. Springer. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proceedings of the National Academy of Sciences, USA , 1994, 91 (9): 36526. 10

    work page 1994